Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver–kidney transplant recipients

Background De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney transplantation (SLKT). We hypothesized that length of hospital stay (LOS) might be associated with de novo DSA development of due to the...

Description complète

Détails bibliographiques

Auteurs principaux:	Masahiko Yazawa, Orsolya Cseprekal, Ryan A. Helmick, Manish Talwar, Vasanthi Balaraman, Pradeep S. B. Podila, Sallyanne Fossey, Sanjaya K. Satapathy, James D. Eason, Miklos Z. Molnar
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2020-01-01
Collection:	Renal Failure
Sujets:	donor specific antibody dsa de novo dsa simultaneous liver–kidney transplantation length of hospital stay hospitalization
Accès en ligne:	http://dx.doi.org/10.1080/0886022X.2019.1705338
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!